Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | 2% | 8.2% | 15.1% |
| Success rate | 80% | 68% | 82% |
| Transactions |
5
100% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Director | Adamas Pharmaceuticals Inc | March 1, 2014 - |
| Independent Chairman of the Board | Chimerix Inc | June 20, 2018 - |
| Independent Director | Chimerix Inc | Jan. 1, 2005 - June 1, 2018 |
| Independent Director | Evofem Biosciences Inc | July 1, 2014 - Jan. 17, 2018 |
Search